Report Detail

Pharma & Healthcare Global Mupirocin Ointment Supply, Demand and Key Producers, 2026-2032

  • RnM4667364
  • |
  • 22 January, 2026
  • |
  • Global
  • |
  • 128 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

The global Mupirocin Ointment market size is expected to reach $ 627 million by 2032, rising at a market growth of 3.1% CAGR during the forecast period (2026-2032).
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
The mupirocin ointment market is driven by the increasing prevalence of skin infections, including impetigo, as well as the rising incidence of antibiotic-resistant bacterial strains like MRSA (methicillin-resistant Staphylococcus aureus). Mupirocin ointment is widely used as a topical antibiotic for treating various bacterial skin infections, making it an essential product in both hospitals and community healthcare settings. The growing awareness of effective wound care, along with increased healthcare access in developing regions, is also contributing to the demand for mupirocin ointment.
A key challenge in the mupirocin ointment market is the potential for bacterial resistance due to the overuse or misuse of antibiotics, which can reduce the long-term efficacy of the product. Additionally, competition from alternative topical antibiotics and newer antimicrobial therapies could limit market growth. Pricing pressures, particularly in regions with generic product availability, may also impact market share and profitability for branded formulations. Furthermore, stringent regulatory requirements for manufacturing and product approval add to the complexity of market entry for new players.
Currently, global production of Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is Glenmark Pharms, who owns 37% revenue market share. As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share. Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest sold channel.
This report studies the global Mupirocin Ointment production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Mupirocin Ointment and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Mupirocin Ointment that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Mupirocin Ointment total production and demand, 2021-2032, (K Units)
Global Mupirocin Ointment total production value, 2021-2032, (USD Million)
Global Mupirocin Ointment production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Mupirocin Ointment consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Mupirocin Ointment domestic production, consumption, key domestic manufacturers and share
Global Mupirocin Ointment production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Mupirocin Ointment production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Mupirocin Ointment production by Sales Channel, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Mupirocin Ointment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Glenmark Pharms, Glaxosmithkline, SmithKline & French, Humanwell Healthcare, Taro Pharmaceutical, Teva, Perrigo, Hanzhou Zhuyangxin Pharmaceutical, GSK, Sun Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Mupirocin Ointment market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Sales Channel. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Mupirocin Ointment Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Mupirocin Ointment Market, Segmentation by Type:
Below 10g
10g-20g
Above 20g
Global Mupirocin Ointment Market, Segmentation by Sales Channel:
Hospital
Retail Pharmacy
Others
Companies Profiled:
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
GSK
Sun Pharmaceutical
Bausch Health
Key Questions Answered:
1. How big is the global Mupirocin Ointment market?
2. What is the demand of the global Mupirocin Ointment market?
3. What is the year over year growth of the global Mupirocin Ointment market?
4. What is the production and production value of the global Mupirocin Ointment market?
5. Who are the key producers in the global Mupirocin Ointment market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Mupirocin Ointment Introduction
  • 1.2 World Mupirocin Ointment Supply & Forecast
    • 1.2.1 World Mupirocin Ointment Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Mupirocin Ointment Production (2021-2032)
    • 1.2.3 World Mupirocin Ointment Pricing Trends (2021-2032)
  • 1.3 World Mupirocin Ointment Production by Region (Based on Production Site)
    • 1.3.1 World Mupirocin Ointment Production Value by Region (2021-2032)
    • 1.3.2 World Mupirocin Ointment Production by Region (2021-2032)
    • 1.3.3 World Mupirocin Ointment Average Price by Region (2021-2032)
    • 1.3.4 North America Mupirocin Ointment Production (2021-2032)
    • 1.3.5 Europe Mupirocin Ointment Production (2021-2032)
    • 1.3.6 Israel Mupirocin Ointment Production (2021-2032)
    • 1.3.7 Japan Mupirocin Ointment Production (2021-2032)
    • 1.3.8 China Mupirocin Ointment Production (2021-2032)
    • 1.3.9 India Mupirocin Ointment Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Mupirocin Ointment Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Mupirocin Ointment Major Market Trends

2 Demand Summary

  • 2.1 World Mupirocin Ointment Demand (2021-2032)
  • 2.2 World Mupirocin Ointment Consumption by Region
    • 2.2.1 World Mupirocin Ointment Consumption by Region (2021-2026)
    • 2.2.2 World Mupirocin Ointment Consumption Forecast by Region (2027-2032)
  • 2.3 United States Mupirocin Ointment Consumption (2021-2032)
  • 2.4 China Mupirocin Ointment Consumption (2021-2032)
  • 2.5 Europe Mupirocin Ointment Consumption (2021-2032)
  • 2.6 Japan Mupirocin Ointment Consumption (2021-2032)
  • 2.7 South Korea Mupirocin Ointment Consumption (2021-2032)
  • 2.8 ASEAN Mupirocin Ointment Consumption (2021-2032)
  • 2.9 India Mupirocin Ointment Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Mupirocin Ointment Production Value by Manufacturer (2021-2026)
  • 3.2 World Mupirocin Ointment Production by Manufacturer (2021-2026)
  • 3.3 World Mupirocin Ointment Average Price by Manufacturer (2021-2026)
  • 3.4 Mupirocin Ointment Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Mupirocin Ointment Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Mupirocin Ointment in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Mupirocin Ointment in 2025
  • 3.6 Mupirocin Ointment Market: Overall Company Footprint Analysis
    • 3.6.1 Mupirocin Ointment Market: Region Footprint
    • 3.6.2 Mupirocin Ointment Market: Company Product Type Footprint
    • 3.6.3 Mupirocin Ointment Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Mupirocin Ointment Production Value Comparison
    • 4.1.1 United States VS China: Mupirocin Ointment Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Mupirocin Ointment Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Mupirocin Ointment Production Comparison
    • 4.2.1 United States VS China: Mupirocin Ointment Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Mupirocin Ointment Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Mupirocin Ointment Consumption Comparison
    • 4.3.1 United States VS China: Mupirocin Ointment Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Mupirocin Ointment Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Mupirocin Ointment Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Mupirocin Ointment Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Mupirocin Ointment Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Mupirocin Ointment Production (2021-2026)
  • 4.5 China Based Mupirocin Ointment Manufacturers and Market Share
    • 4.5.1 China Based Mupirocin Ointment Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Mupirocin Ointment Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Mupirocin Ointment Production (2021-2026)
  • 4.6 Rest of World Based Mupirocin Ointment Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Mupirocin Ointment Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Mupirocin Ointment Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Mupirocin Ointment Production (2021-2026)

5 Market Analysis by Type

  • 5.1 World Mupirocin Ointment Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Below 10g
    • 5.2.2 10g-20g
    • 5.2.3 Above 20g
  • 5.3 Market Segment by Type
    • 5.3.1 World Mupirocin Ointment Production by Type (2021-2032)
    • 5.3.2 World Mupirocin Ointment Production Value by Type (2021-2032)
    • 5.3.3 World Mupirocin Ointment Average Price by Type (2021-2032)

6 Market Analysis by Sales Channel

  • 6.1 World Mupirocin Ointment Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Sales Channel
    • 6.2.1 Hospital
    • 6.2.2 Retail Pharmacy
    • 6.2.3 Others
  • 6.3 Market Segment by Sales Channel
    • 6.3.1 World Mupirocin Ointment Production by Sales Channel (2021-2032)
    • 6.3.2 World Mupirocin Ointment Production Value by Sales Channel (2021-2032)
    • 6.3.3 World Mupirocin Ointment Average Price by Sales Channel (2021-2032)

7 Company Profiles

  • 7.1 Glenmark Pharms
    • 7.1.1 Glenmark Pharms Details
    • 7.1.2 Glenmark Pharms Major Business
    • 7.1.3 Glenmark Pharms Mupirocin Ointment Product and Services
    • 7.1.4 Glenmark Pharms Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Glenmark Pharms Recent Developments/Updates
    • 7.1.6 Glenmark Pharms Competitive Strengths & Weaknesses
  • 7.2 Glaxosmithkline
    • 7.2.1 Glaxosmithkline Details
    • 7.2.2 Glaxosmithkline Major Business
    • 7.2.3 Glaxosmithkline Mupirocin Ointment Product and Services
    • 7.2.4 Glaxosmithkline Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Glaxosmithkline Recent Developments/Updates
    • 7.2.6 Glaxosmithkline Competitive Strengths & Weaknesses
  • 7.3 SmithKline & French
    • 7.3.1 SmithKline & French Details
    • 7.3.2 SmithKline & French Major Business
    • 7.3.3 SmithKline & French Mupirocin Ointment Product and Services
    • 7.3.4 SmithKline & French Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 SmithKline & French Recent Developments/Updates
    • 7.3.6 SmithKline & French Competitive Strengths & Weaknesses
  • 7.4 Humanwell Healthcare
    • 7.4.1 Humanwell Healthcare Details
    • 7.4.2 Humanwell Healthcare Major Business
    • 7.4.3 Humanwell Healthcare Mupirocin Ointment Product and Services
    • 7.4.4 Humanwell Healthcare Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Humanwell Healthcare Recent Developments/Updates
    • 7.4.6 Humanwell Healthcare Competitive Strengths & Weaknesses
  • 7.5 Taro Pharmaceutical
    • 7.5.1 Taro Pharmaceutical Details
    • 7.5.2 Taro Pharmaceutical Major Business
    • 7.5.3 Taro Pharmaceutical Mupirocin Ointment Product and Services
    • 7.5.4 Taro Pharmaceutical Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Taro Pharmaceutical Recent Developments/Updates
    • 7.5.6 Taro Pharmaceutical Competitive Strengths & Weaknesses
  • 7.6 Teva
    • 7.6.1 Teva Details
    • 7.6.2 Teva Major Business
    • 7.6.3 Teva Mupirocin Ointment Product and Services
    • 7.6.4 Teva Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Teva Recent Developments/Updates
    • 7.6.6 Teva Competitive Strengths & Weaknesses
  • 7.7 Perrigo
    • 7.7.1 Perrigo Details
    • 7.7.2 Perrigo Major Business
    • 7.7.3 Perrigo Mupirocin Ointment Product and Services
    • 7.7.4 Perrigo Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Perrigo Recent Developments/Updates
    • 7.7.6 Perrigo Competitive Strengths & Weaknesses
  • 7.8 Hanzhou Zhuyangxin Pharmaceutical
    • 7.8.1 Hanzhou Zhuyangxin Pharmaceutical Details
    • 7.8.2 Hanzhou Zhuyangxin Pharmaceutical Major Business
    • 7.8.3 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Product and Services
    • 7.8.4 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.8.5 Hanzhou Zhuyangxin Pharmaceutical Recent Developments/Updates
    • 7.8.6 Hanzhou Zhuyangxin Pharmaceutical Competitive Strengths & Weaknesses
  • 7.9 GSK
    • 7.9.1 GSK Details
    • 7.9.2 GSK Major Business
    • 7.9.3 GSK Mupirocin Ointment Product and Services
    • 7.9.4 GSK Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.9.5 GSK Recent Developments/Updates
    • 7.9.6 GSK Competitive Strengths & Weaknesses
  • 7.10 Sun Pharmaceutical
    • 7.10.1 Sun Pharmaceutical Details
    • 7.10.2 Sun Pharmaceutical Major Business
    • 7.10.3 Sun Pharmaceutical Mupirocin Ointment Product and Services
    • 7.10.4 Sun Pharmaceutical Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Sun Pharmaceutical Recent Developments/Updates
    • 7.10.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
  • 7.11 Bausch Health
    • 7.11.1 Bausch Health Details
    • 7.11.2 Bausch Health Major Business
    • 7.11.3 Bausch Health Mupirocin Ointment Product and Services
    • 7.11.4 Bausch Health Mupirocin Ointment Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.11.5 Bausch Health Recent Developments/Updates
    • 7.11.6 Bausch Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Mupirocin Ointment Industry Chain
  • 8.2 Mupirocin Ointment Upstream Analysis
    • 8.2.1 Mupirocin Ointment Core Raw Materials
    • 8.2.2 Main Manufacturers of Mupirocin Ointment Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Mupirocin Ointment Production Mode
  • 8.6 Mupirocin Ointment Procurement Model
  • 8.7 Mupirocin Ointment Industry Sales Model and Sales Channels
    • 8.7.1 Mupirocin Ointment Sales Model
    • 8.7.2 Mupirocin Ointment Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Mupirocin Ointment. Industry analysis & Market Report on Mupirocin Ointment is a syndicated market report, published as Global Mupirocin Ointment Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Mupirocin Ointment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,480.00
    $6,720.00
    $8,960.00
    3,463.04
    5,194.56
    6,926.08
    4,170.88
    6,256.32
    8,341.76
    684,051.20
    1,026,076.80
    1,368,102.40
    378,112.00
    567,168.00
    756,224.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report